Olema Pharmaceuticals, Inc. (OLMA)
25.04
-0.60
(-2.36%)
USD |
NASDAQ |
Dec 30, 16:00
25.04
0.00 (0.00%)
After-Hours: 18:03
Olema Pharmaceuticals Total Liabilities (Quarterly): 44.96M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Cidara Therapeutics, Inc. | 96.26M |
| Cogent Biosciences, Inc. | 123.47M |
| Replimune Group, Inc. | 126.11M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 352.45M |
| Shareholders Equity (Quarterly) | 307.49M |
| Debt to Equity Ratio | 0.0146 |
| Current Ratio | 8.026 |
| Net Debt Paydown Yield | -0.07% |